iHeartMedia, Empire BlueCross BlueShield partner with Common Threads to Increase Food Security and Nutrition Equity in New York – Yahoo Finance

Brooklyn’s Walter Weaver Elementary hosts free food distribution event and cooking demonstration to celebrate expanded collaboration
NEW YORK, December 09, 2022–(BUSINESS WIRE)–iHeartMedia and Empire BlueCross BlueShield partnered with non-profit Common Threads to provide hands-on culinary programming focused on ‘food as medicine’ yesterday in Brooklyn, extending their multi-year partnership to increase food security and nutrition equity in underserved communities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221209005496/en/
iHeartIMPACT, Empire BlueCross BlueShield, and Common Threads hosted a food distribution event with the New York Liberty at P.S. 398 Walter Weaver Elementary School in Brooklyn, providing hundreds of students with bags of fresh produce and a cooking demonstration from Common Threads instructors on how to prepare a healthy meal. (Photo: Business Wire)
More than 1.5 million New York City residents, and one in three children, experience food insecurity. iHeartMedia, Empire BlueCross BlueShield, and Common Threads are launching culturally responsive, hands-on food as medicine programming at P.S. 398 Walter Weaver Elementary in Brooklyn to help students and families access nutritious food and build skills to prepare meals that can improve their health outcomes.
Just last year, Empire funded the development of a permanent food pantry at the school, which has hosted recurring food distributions for local families. The incorporation of Common Threads into the partnership extends programming at the school to include ongoing cooking classes and nutrition education for Walter Weaver students and families.
To celebrate this expansion, the organizations hosted a food distribution to provide fresh produce for hundreds of families, alongside a cooking class with Food Bank for New York City to teach participants how to prepare a healthy meal. Attendees included Common Threads Director of Development, Emily Conrath, Brooklyn native and co-host of iHeartMedia’s Elvis Duran & the Morning Show, Skeery Jones, the New York Liberty, and leadership from Empire.
“We’re proud to have built the food pantry here at Walter Weaver last year, and it means so much to us to be able to come back this year to support programs that are teaching the students and their families how to use these resources to eat and enjoy healthy food,” says Bernie Weiss, President, iHeartMedia Multiplatform Group – New York. “We’re grateful to Empire and Common Threads teams for making critical programs like these sustainable and accessible to the families that need them the most.”
Globally, one of every five deaths is attributable to a suboptimal diet, while diets rich in fruits and vegetables can significantly lower risk of obesity, heart disease, stroke, diabetes, and certain types of cancer. Deficiencies in certain nutrients may exacerbate mental health conditions, such as depression, bipolar disorder, schizophrenia, and obsessive-compulsive disorder (OCD). Students with a healthy, balanced diet are more likely to have stronger immune systems, lower risk of diabetes and heart disease, and live longer. A healthy diet can boost brain function and improve mood to make learning optimal.
“Food insecurity has significant detrimental effects on health, especially in children, and can leave devastating, long-lasting impacts across communities, so it is critical we develop and implement culturally response, hands-on programming and food distributions for our neighbors who need it most,” said Mark Levy, MD, president, Empire BlueCross BlueShield HealthPlus. “This latest partnership reflects Empire’s ongoing support for strategic, innovative opportunities that address the health needs of some of some of our most vulnerable, underserved communities in New York.”
“Food is truly at the heart of our communities, and when we announced the opening of the food pantry at P.S. 398 last year, we specifically talked about doing it with heart and soul. That’s why, as part of our mission to improve the health of all New Yorkers we are announcing this new partnership with Common Threads to take our commitment one step further,” said Alan J. Murray, president & CEO, Empire BlueCross BlueShield in New York.
Common Threads’ nutrition education curriculum teaches students the tools to identify and cook with affordable and healthy ingredients, increase their vegetable, fruit, whole grain, and lean protein intake, and lower their sugar intake. The curriculum embeds culturally relevant content and teaching practices to effectively increase students’ knowledge and skills to cook nutritious meals at home and improve their physical and mental health outcomes.
“Common Threads has integrated healthy eating into schools and communities taking an innovative approach to culturally responsive cooking and nutrition education,” says Common Threads Executive Director Linda Novick O’Keefe. “Cooking is a joyful way to improve our relationships with food no matter how old you are and the simple acts of selecting and preparing healthy meals supports and improves good health and well-being and eliminates preventable diseases.”
About iHeartIMPACT & Empire BlueCross BlueShield Partnership
iHeartIMPACT is a division of iHeartMedia that focuses on aligning brands with nonprofit organizations. Empire BlueCross BlueShield and its affiliated companies are working with iHeartIMPACT to support a series of nutrition education programs in a total of six schools across Los Angeles, New York, Atlanta and Indianapolis. This partnership with national health and wellness organization, Common Threads, is an extension of the companies’ multi-year commitment to addressing food insecurity and whole-health for communities across the country.
About Common Threads
Common Threads is a national nonprofit that provides children and families with cooking and nutrition education, striving to equip communities with the necessary information to make affordable, nutritious, and appealing food choices wherever they live, work, learn, and play. By December 31,2029 they committed to distributing 1,447,000 nutritious meals and snacks, and 1,228,500 hours of nutrition education. They aim to tackle the critical issues of limited access to healthy foods and nutrition-related health disparities in communities by reaching over 260,000 participants in low-income households across the United States, to offer culturally relevant nutrition education and hands-on cooking skills at community centers including schools, community organizations, and healthcare providers.
For more information about Common Threads visit commonthreads.org.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221209005496/en/
Contacts
Michael Perry
Michael.perry@anthem.com
617-519-6206
Ambrx Biopharma Inc (NASDAQ: AMAM) announced preliminary safety and efficacy data from its Phase 2 ACE‑Breast-03 study. The data presented demonstrated a 51.7% overall response rate (ORR) and 100% disease control rate (DCR) after treatment with ARX788 in HER2-positive mBC patients who are resistant or refractory to T-DM1. ACE-Breast-03 is a Phase 2 study of ARX788 for patients whose metastatic disease is resistant or refractory to T-DXd, T-DM1, or tucatinib-containing regimens. Related: Ambrx Bi
A key decision from Eli Lilly could alight the obesity treatment landscape again, an analyst said Friday as LLY stock lingers near a record.
The initial spike in Tilray and other cannabis stocks came after reports surfaced that Senate Majority Leader Chuck Schumer hoped to pass two cannabis reform bills before the holiday break. Top Republicans, however, managed to prevent the marijuana reform provisions from being attached to the version that was finalized Tuesday night. Federal banking laws keep Canadian marijuana companies like Tilray from doing business even in U.S. states that have legalized pot.
With approval of Veru's (NASDAQ: VERU) drug sabizabulin for severe COVID-19 in serious question, the company's shareholders have every right to be a bit flighty at the moment. The most significant near-term risk to Veru's stock is that regulators at the Food and Drug Administration (FDA) might decide to rebuff its request to commercialize sabizabulin with an Emergency Use Authorization (EUA). In November, a non-binding advisory committee at the FDA voted against the company, finding with an 8-5 vote that the medicine's purported efficacy characteristics were not compelling enough for an expedited approval in light of the known risks of treatment and the ongoing public health need for such therapies.
Cloud computing is not a new frontier in health care, but it is finally starting to bear some fruit, AWS exec Dr. Taha Kass-Hout, told Yahoo Finance.
With this in mind, we asked three Motley Fool contributors to pick high-flying stocks in 2022 that can keep soaring in 2023. Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Merck (NYSE: MRK), and Vertex Pharmaceuticals (NASDAQ: VRTX). Keith Speights (Axsome Therapeutics): With just a few weeks left in the year, shares of Axsome Therapeutics have more than doubled.
The senior housing REIT has always had a high yield, but its focus on nursing homes has been a particular problem of late.
Mirati Therapeutics' pain continued Thursday amid a series of analyst downgrades after MRTX stock lost about half of its value in three days.
The Mark Cuban Cost Plus Drug Company is teaming up with EmsanaRx, a pharmacy benefit manager, to make lower-cost prescription drugs more accessible to patients through their employers.
There are many such corporations to consider on the market, but let's examine two: Guardant Health (NASDAQ: GH) and Sarepta Therapeutics (NASDAQ: SRPT). Progress in cancer research is always important as cancer is a leading cause of death worldwide. Guardant Health focuses on developing liquid biopsies — tests that help detect signs of cancer from blood samples.
Sanofi and Regeneron's Dupixent moved closer to regulatory approval to treat another skin disease in the European Union.
Recent initial public offering Arcellx forged a $325 million cancer deal with Gilead Sciences on Friday, and the IPO stock broke out.
As the fighting from the Global War on Terror fades into the rearview for the public, so too does the cost of those wars, even if that cost will continue to take its toll for years to come.
Yahoo Finance health care reporter Anjalee Khemlani highlights the latest news surrounding nearly 2,500 cases linking Zantac to cancer.
WATCH: TennCare may be parting with Le Bonheur Children's Hospital
Baptist Health System, one of the region’s largest health care providers, plans to invest $14 million to expand its Mission Trail Baptist Hospital. The South San Antonio investment comes as Baptist is shuffling top leadership at multiple Alamo City hospitals. One of those changes is at Mission Trail, where Baptist has appointed Erik Frederick as the hospital’s new CEO.
Exelixis Inc (NASDAQ: EXEL) announced that the CONTACT-01 study did not meet its primary endpoint of overall survival at the final analysis. CONTACT-01 is a phase 3 trial evaluating Cabometyx (cabozantinib) in combination with Tecentriq (atezolizumab) versus docetaxel in metastatic non-small cell lung cancer (NSCLC) without actionable mutations who experienced disease progression on or after treatment. Related: Exelixis Announces Detailed Results From Late-Stage Cabometyx Combo Trial In Kidney C
Intensive care unit availability has dropped below 15% in southwest Illinois as respiratory viruses lead to serious illness in some patients.
Dasha Burobina/Getty Images “My daughter is asking to join ballet (which practices indoors) in the new year, but with flu, RSV, and COVID circulating, is it really a good idea to let her do this? I want to return to normal, but I'm nervous!” After more than two years of ever-changing public health guidelines, scary headlines and grim statistics, it is understandable to crave a safe return to normal yet be hesitant to do so. We want our kids to attend their favorite activities without worrying ab
Al Roker is back in the hospital due to "complications" less than a week after being released during a blood clot scare, Hoda Kotb announced Thursday.

source